Abstract : We have examined the effects of transient global ischemia on both the gene expression levels and the functionality of GABAB receptors in rat brain, using antisense in situ hybridization and electrophysiological evaluations. At the level of gene expression, no significant change in GABAB receptor expression was observed in any hippocampal subfield at either 6 or 12 h after challenge. At 24 h postchallenge, however, a significant decrease in GABAB receptor expression was observed in both the CA1 and CA3 subfields, whereas no change was observed in the dentate granule cell layer. Although expression in both the vulnerable CA1 and less vulnerable CA3 subfields was diminished at this time postchallenge, there was no significant difference in the degree of the diminished expression between these subfields. At the functional level, the dose‐dependent ability of baclofen (1‐100 μM) to inhibit an evoked excitatory postsynaptic potential (f‐EPSP) in the CA1 subfield was evaluated at 24 h postischemia, in comparison with the dose‐response observed in sham‐operated subjects. No significant differences were observed in the efficacy of GABAB receptor‐mediated inhibition of the elicited f‐EPSP at any of the baclofen concentrations examined. These data demonstrate that although the mRNA expression levels for the GABAB receptor are diminished in both vulnerable and less vulnerable neurons of Ammon's horn at 24 h following transient global ischemia, the functionality of the GABAB receptor system is maintained at this time postchallenge.
Journal of Neurochemistry – Wiley
Published: Jan 1, 1999
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud